Prognostic performance of MRI LI-RADS version 2018 features and clinical-pathological factors in alpha-fetoprotein-negative hepatocellular carcinoma

DOI: https://doi.org/10.1007/s00261-024-04278-9
IF: 2.4
2024-04-21
Abdominal Radiology
Abstract:To evaluate the role of the magnetic resonance imaging (MRI) Liver Imaging Reporting and Data System (LI-RADS) version 2018 features and clinical-pathological factors for predicting the prognosis of alpha-fetoprotein (AFP)-negative (≤ 20 ng/ml) hepatocellular carcinoma (HCC) patients, and to compare with other traditional staging systems.
radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?